Avantor, Inc. (AVTR) Financials
AVTR Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
March 31, 2025 | 12.3 billion | 6.2 billion |
Dec. 31, 2024 | 12.1 billion | 6.2 billion |
Sept. 30, 2024 | 12.8 billion | 7.3 billion |
June 30, 2024 | 12.7 billion | 7.3 billion |
AVTR Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
March 31, 2025 | 106.9 million | 12.4 million |
Dec. 31, 2024 | 145.8 million | 11.1 million |
Sept. 30, 2024 | 204.0 million | 11.9 million |
June 30, 2024 | 235.3 million | 11.1 million |
AVTR Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
March 31, 2025 | 60.4 million |
Dec. 31, 2024 | 500.4 million |
Sept. 30, 2024 | 57.8 million |
June 30, 2024 | 92.9 million |
AVTR Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
March 31, 2025 | 315.7 million | - | - |
Dec. 31, 2024 | 261.9 million | - | - |
Sept. 30, 2024 | 285.3 million | 4.7 billion | - |
June 30, 2024 | 272.6 million | 4.9 billion | - |
AVTR Shares Outstanding
AVTR Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
March 31, 2025 | 34.7 million | - | 387.5 million | - |
Dec. 31, 2024 | 27.5 million | - | 371.4 million | - |
Sept. 30, 2024 | 40.8 million | - | 439.8 million | - |
June 30, 2024 | 45.8 million | - | 396.0 million | - |
AVTR Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
March 31, 2025 | 1.6 billion | 1.0 billion |
Dec. 31, 2024 | 1.7 billion | 1.1 billion |
Sept. 30, 2024 | 1.7 billion | 1.2 billion |
June 30, 2024 | 1.7 billion | 1.1 billion |
AVTR Revenue by Segment
Graph available only for supporters. Become a supporter to see it.
AVTR
Price: $13.43
52 week price:
Payout Ratio Range:
Earnings Per Share: 1.04 USD
P/E Ratio: 12.80
Exchange: NYQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 16.7 million
Market Capitalization: 9.1 billion